HES1 and nonpapillary renal cell carcinoma: Taken together, it is likely that HES1 plays an oncogenic role in ccRCC development by directly targeting miR-138–2, and miR-138–2 acts as a tumor-suppressor in ccRCC development through the direct targeting of the oncogenic NOTCH signaling pathway.